Larvol Delta - A-Phase-12-Study-CB103-With-or-Without-Venetoclax-in-Patients-With-NOTCH-ACC

CB-103 - Cellestia Biotech

Venclexta (venetoclax) - Roche, AbbVie

Lenvima (lenvatinib) - Eisai, Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT05774899

Mar 20, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next